|
Back
Homeopathic
and Low Dose Products for Cancer Prevention and Treatment
principle Investigators: Wayne B. Jonas, MD; Radha K. Maheshwari, PhD
Affiliations: Uniformed Services University of Health Sciences (USUHS);
National Institutes of Health; Amala Cancer Research Center, India;
Industrial Toxicology Research Center, Lucknow, India
Co-Founders: NCCAM,
NCI, NIH
Background: The use of homeopathic remedies and low-dose carcinogens for
cancer treatment and prevention has been more prevalent outside of the
United States. Reports of successful treatments have been verified by the NIH Best Case Series program. This multi-year project exploits
collaboration between USUHS and Indian research laboratories, and the
capacity to perform lower cost screening efforts in India. Some
homeopathic medicines will be found to have cellular impact on a variety
of cancers, including breast, prostate, lung, liver, brain, oral and
cervical. Prescreening work in India will allow a cost effective way to
determine which remedies have the potential to work against which cancers.
Hypotheses: Low dose carcinogens have anticarcinogenic effects. This
project explores the anticarcinogenic effects of low dose cancer agents
and homeopathic treatments for their ability to prevent and treat cancer.
Method and Materials: This program is located at the Uniformed Services
University of the Health Sciences (USUHS), laboratories at the National
Institutes of Health (NIH), and two laboratories in India. In the first
year, primary screening for activity of homeopathic medicines and low dose
cancer agents against various cancers is being pursued. This screening in
animal models is done in India. Positive results from this preliminary
work will be confirmed and further studies will be pursued with state of
the art molecular biology techniques at USUHS and NIH. Advanced genetic
techniques will be performed at the National Institutes of Health, and
through contract laboratories.
Anticipated results: The cellular and genetic effects of homeopathic
cadmium preparations in normal and prostate cancer cells will be initially
examined. This program will document the clinical affects of homeopathic
treatment and identify which remedies are most promising for further
study. It will also reveal the degree and mechanisms of these effects in
animal and cellular models.
Relationship to SIIB mission and healing: The potential of
impacting cancer, one of the most feared of chronic diseases, could
significantly change the view of conventional practitioners toward
complementary and alternative medicine, and provide new non-toxic
approaches to this disease.
|